Lion Point Capital, LP’s Pacira Biosciences Inc Position
Does Lion Point Capital, LP own Pacira Biosciences Inc (PCRX)? Yes — 13.5K shares worth $305,100 (+1.82% of its 13F portfolio) as of Q1 2026.
Position Value
$305,100
Q1 2026
Shares
13.5K
% of Portfolio
+1.82%
Quarters Held
2
currently held
Position History PCRX
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lion Point Capital, LP’s full portfolio or all institutional holders of PCRX.